These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 33709474)
1. The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance. Castillo JJ; Callander NS; Baljevic M; Sborov DW; Kumar S Am J Hematol; 2021 Jul; 96(7):846-853. PubMed ID: 33709474 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options. Amaador K; Peeters H; Minnema MC; Nguyen TQ; Dendooven A; Vos JMI; Croockewit AJ; van de Donk NWCJ; Jacobs JFM; Wetzels JFM; Sprangers B; Abrahams AC Neth J Med; 2019 Sep; 77(7):243-254. PubMed ID: 31582582 [TBL] [Abstract][Full Text] [Related]
4. Updates in Plasma Cell Dyscrasias and Related Monoclonal Immunoglobulin-Mediated Renal Disease. Midha S; Nadeem O; Selamet U Semin Nephrol; 2022 Nov; 42(6):151352. PubMed ID: 37257390 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity. Ciocchini M; Arbelbide J; Musso CG Int Urol Nephrol; 2017 Dec; 49(12):2171-2175. PubMed ID: 28425076 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Leung N; Bridoux F; Hutchison CA; Nasr SH; Cockwell P; Fermand JP; Dispenzieri A; Song KW; Kyle RA; Blood; 2012 Nov; 120(22):4292-5. PubMed ID: 23047823 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathological characteristics and prognosis in patients with monoclonal gammopathy and renal damage in central China: a multicenter retrospective cohort study. He H; Wang Z; Xu J; Liu Y; Shao Y; Hou Y; Gu J; Hu R; Xing G Sci Rep; 2024 Apr; 14(1):7667. PubMed ID: 38561447 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal Gammopathy and Its Association with Progression to Kidney Failure and Mortality in Patients with CKD. Sy-Go JPT; Moubarak S; Vaughan LE; Klomjit N; Viehman JK; Fervenza FC; Zand L Clin J Am Soc Nephrol; 2024 Mar; 19(3):319-328. PubMed ID: 37948069 [TBL] [Abstract][Full Text] [Related]
10. The clinical implication of monoclonal gammopathies: monoclonal gammopathy of undetermined significance and of renal significance. Batko K; Malyszko J; Jurczyszyn A; Vesole DH; Gertz MA; Leleu X; Suska A; Krzanowski M; Sułowicz W; Malyszko JS; Krzanowska K Nephrol Dial Transplant; 2019 Sep; 34(9):1440-1452. PubMed ID: 30169860 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal gammopathy of renal significance: Multidisciplinary approach to diagnosis and treatment. Karam S; Haidous M; Dalle IA; Dendooven A; Moukalled N; Van Craenenbroeck A; Bazarbachi A; Sprangers B Crit Rev Oncol Hematol; 2023 Mar; 183():103926. PubMed ID: 36736510 [TBL] [Abstract][Full Text] [Related]
12. The Role of Bone Marrow Biopsy Evaluation in the Workup for Monoclonal Gammopathy of Renal Significance: A Diagnosis of Exclusion. Metcalf BD; Huang J; Kanaan HD; Abukhaled J; Li W; Samarapungavan D; Zarouk S; Zhang PL Arch Pathol Lab Med; 2024 Mar; 148(3):e57-e62. PubMed ID: 37787408 [TBL] [Abstract][Full Text] [Related]
13. Kidney Histopathologic Spectrum and Clinical Indicators Associated with MGRS. Yong ZH; Yu XJ; Liu JX; Zhou FD; Wang SX; Zhao MH Clin J Am Soc Nephrol; 2022 Apr; 17(4):527-534. PubMed ID: 35210280 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal gammopathy of renal significance (MGRS): Real-world data on outcomes and prognostic factors. Gozzetti A; Guarnieri A; Zamagni E; Zakharova E; Coriu D; Bittrich M; Pika T; Tovar N; Schutz N; Ciofini S; Peña C; Rocchi S; Rassner M; Avivi I; Waszczuk-Gajda A; Chhabra S; Usnarska-Zubkiewicz L; González-Calle V; Mateos MV; Bocchia M; Bigi F; Füllgraf H; Bhasin-Chhabra B; Gentile M; Davila J; Vesole DH; Cavo M; Thapa B; Crusoe E; Einsele H; Legiec W; Charliński G; Jurczyszyn A Am J Hematol; 2022 Jul; 97(7):877-884. PubMed ID: 35389534 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal Gammopathy of Renal Significance (MGRS): Prospects for Treatment in Integrated Chinese and Western Medicine. Li JP; Du YT; Li S; Rao XR Chin J Integr Med; 2021 Sep; 27(9):643-648. PubMed ID: 34105098 [TBL] [Abstract][Full Text] [Related]
16. Monoclonal gammopathy of renal significance (MGRS) increases the risk for progression to multiple myeloma: an observational study of 2935 MGUS patients. Steiner N; Göbel G; Suchecki P; Prokop W; Neuwirt H; Gunsilius E Oncotarget; 2018 Jan; 9(2):2344-2356. PubMed ID: 29416776 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal gammopathy: The good, the bad and the ugly. Glavey SV; Leung N Blood Rev; 2016 May; 30(3):223-31. PubMed ID: 26732417 [TBL] [Abstract][Full Text] [Related]
18. [The value of serum free light chain in differential diagnosis of monoclonal gammopathy of renal significance]. Li C; Wen YB; Li H; Su W; Li J; Cai JF; Chen LM; Li XM; Li XW Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(30):2344-2348. PubMed ID: 28822451 [No Abstract] [Full Text] [Related]
19. Clinicopathological characteristics of patients with paraproteinemia and renal damage. Tang X; Wan F; Yu J; Li X; Yang R; Zhu B Eur J Med Res; 2021 Jul; 26(1):68. PubMed ID: 34217367 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal gammopathy of renal significance (MGRS)-related AL amyloidosis complicated by amyloid myopathy: a case report. Ono E; Ishii A; Higashi Y; Koita N; Ayaki T; Tanigaki K; Takayanagi S; Kondo N; Sakai K; Endo S; Yokoi H; Matsubara T; Minamiguchi S; Nishino I; Takahashi R; Yanagita M BMC Nephrol; 2021 Feb; 22(1):74. PubMed ID: 33639890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]